High lifetime risk of cancer in primary sclerosing cholangitis

MMH Claessen, FP Vleggaar, KMAJ Tytgat, PD (Peter) Siersema, Henk van Buuren

Research output: Contribution to journalArticleAcademicpeer-review

263 Citations (Scopus)

Abstract

Background/Aims: Primary sclerosing cholangitis (PSC) patients are at risk for developing cholangiocarcinoma (CCA) and colorectal carcinoma (CRC). Our aim was to assess the risk of malignancies and their influence on survival. Methods: Data from PSC patients diagnosed between 1980 and 2006 in two university hospitals were retrieved. The Kaplan-Meier method and a time-dependent Cox regression model were used to calculate risks of malignancies and their influence on survival. Results: Two hundred and eleven patients were included, 143 (68%) were male and 126 (60%) had inflammatory bowel disease (IBD). Median transplantation-free survival was 14 years. The risk of CCA after 10 and 20 years was 9% and 9%, respectively. In patients with concomitant IBD the 10-year and 20-year risks for CRC were 14% and 31%, which was significantly higher than for patients without 1131) (2% and 2% (P = 0.008)). CCA, cholangitis, and age at entry were independent risk factors for the combined endpoint death or liver transplantation. Risk factors for the endpoint death were CCA, CRC, age, and symptomatic presentation. Conclusions: Patients with PSC and IBD have a high long-term risk of developing CRC and this risk is about threefold higher than the risk for CCA. Both malignancies are associated with decreased survival. (C) 2008 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)158-164
Number of pages7
JournalJournal of Hepatology
Volume50
Issue number1
DOIs
Publication statusPublished - 2009

Cite this